atai Life Sciences (ATAI)
(Delayed Data from NSDQ)
$1.51 USD
-0.06 (-3.82%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $1.49 -0.02 (-1.32%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 30% (76 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.68 | 9.99 |
Current Quarter Estimate | -0.17 | 0.69 | 61.00 |
Year Ago Quarter Estimate | -0.21 | 1.31 | 54.84 |
Next Quarter Estimate | -0.18 | 0.72 | 63.00 |
Next Year Estimate | -0.67 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -168.00 | 14.40 | 15.67 |
Next Year | 0.00 | 13.10 | 9.31 |
Last 5 Years | NA | 4.20 | 8.10 |
Next 5 Years | NA | 12.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 13.83 |
Price/Book (MRQ) | 1.18 | 2.74 |
Price/Cash Flow (MRFY) | NA | 14.54 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -12,810.51% | -179.95% |
Return on Equity (TTM) | -43.21% | -104.91% |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.